Compare
IQVIA vs Thermo Fisher Scientific (IQV vs TMO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year IQVIA (IQV) returned +29.4% and Thermo Fisher Scientific (TMO) +22.4%; so far this year the figures are +20.6% and +19.9%.
Thermo Fisher Scientific is the larger company by market value, about 5.7 times the size of IQVIA.
On trailing earnings, IQV trades at 33.1 times and TMO at 36.6 times.
Revenue grew +8.8% at IQV and +8.3% at TMO over the last year.
IQV pays no dividend. TMO yields 0.26%.
Data as of the latest close. Not investment advice.
Relative performance
| IQV | TMO | |
|---|---|---|
| Price | $271.83 | $694.76 |
| 1-day | +2.62% | +2.63% |
| YTD | +20.59% | +19.90% |
| 1 year | +29.37% | +22.39% |
| 3 years | +51.01% | +57.50% |
| Market cap | $44.8B | $257.4B |
| P/E | 33.1 | 36.6 |
| P/S | 2.59 | 5.44 |
| P/B | 6.73 | 4.70 |
| Revenue growth | +8.80% | +8.30% |
| EPS growth | +12.90% | +9.50% |
| Gross margin % | 33.1 | 25.2 |
| Net margin % | 8.1 | 14.9 |
| ROE % | 20.9 | 12.9 |
| Debt / equity | 2.41 | 0.79 |
| FCF yield % | 4.6 | 3.0 |
| Dividend yield % | — | 0.26 |
| Beta | 0.67 | 0.67 |
| RSI (14) | 54.3 | 54.7 |
| Technical rating |